Business Daily from THE HINDU group of publications
Saturday, Dec 02, 2006
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Home Page - Pharmaceuticals
Corporate - Mergers & Acquisitions
Get Latest BSE Quote
Ranbaxy acquires South African firm for Rs 315 cr

Our Bureau

Deal slated for completion next year

New Delhi , Dec. 1

Ranbaxy Laboratories Ltd announced on Friday that it has acquired South Africa's fifth-largest generics player Be-Tabs Pharmaceuticals for $70 million (Rs 315 crore). The acquisition, subject to requisite approvals from South African authorities, is slated for completion in the first quarter of 2007.

According to a Ranbaxy statement, the closely held Be-Tabs Pharmaceuticals — South Africa's largest manufacturer of penicillin formulations with a strong OTC portfolio — has annual sales of about $30 million. The acquisition is to be funded from Ranbaxy's FCCB (foreign currency convertible bonds) proceeds, it said.

Commenting on the acquisition, the Ranbaxy CEO and Managing Director, Mr Malvinder Mohan Singh, said, "The acquisition of Be-Tabs results in considerable synergies and further strengthens Ranbaxy's foothold in South Africa... The move will help us to provide effective disease management solutions in support of the (South African) Government's objective to make healthcare affordable to a wider cross-section of the population."

"It is our clear intent to accelerate our growth in the local market," Mr Desmond Brothers, Chief Executive Officer of Ranbaxy's South African operations, said in the statement. South Africa, the largest pharma market in Africa valued at close to $2 billion, is projected to have a high potential for generic growth. Ranbaxy South Africa commenced its commercial operations in 1996.

Related Stories:
Global consolidation moves — The side effects on Indian pharma
Ranbaxy buys GSK's generic drug unit in Spain
Acquisitions on the radar for Ranbaxy's promoter-scions
Ranbaxy scores hat-trick with Belgian buy

More Stories on : Pharmaceuticals | Mergers & Acquisitions | Ranbaxy Laboratories Ltd

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Adclub BL Hiring

Stories in this Section
Brewing low pressure in Bay `notified'


Thomas Cook to acquire TCI
New fund offers flood the market
DoT tightens norms for subscriber verification
Drop continues in oilseed sowing; pulses acreage up
Inflation rises to 5.45% on costlier minerals
`US-India taking a wise approach to bilateral trade engagement'
Forex reserves jump by $5.9 b in November
First cargo of crude from Sakhalin-1 arrives
Ranbaxy acquires South African firm for Rs 315 cr
No big deal on IT salary front
Hero Honda on the 4-wheeler bandwagon
One crore eggs to be shipped from down South to Patna
Nifty breaches 4,000-mark intra-day
Citibank opens biometric ATMs


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line